Literature DB >> 32281324

A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults.

Jae Hyung Roh1, Jae Hyeong Park2, Hanbyul Lee3, Yong Hoon Yoon1, Minsu Kim1, Yong Giun Kim4, Gyung Min Park4, Jae Hwan Lee1, In Whan Seong1.   

Abstract

BACKGROUND AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is an excessive accumulation of fat into the liver as a result of increased inflammation and insulin resistance. Although there can be common pathogenic mechanisms for NAFLD and hypertension associated with the development of cardiovascular diseases, little data are showing the association between NAFLD and hypertension in a large-scale cohort study. Thus, we evaluated the ability of the fatty liver index (FLI), a surrogate marker of NAFLD, to predict the development of hypertension in healthy individuals.
METHODS: We included 334,280 healthy individuals without known comorbidities who underwent the National Health check-ups in South Korea from 2009 to 2014. The association between the FLI and hypertension was analyzed using multivariate Cox proportional-hazards models.
RESULTS: During a median of 5.2 years' follow-up, 24,678 subjects (7.4%) had new-onset hypertension. We categorized total subjects into quartile groups according to FLI (range: Q1, 0-4.9; Q2, 5.0-12.5; Q3, 12.6-31.0; and Q4, >31.0). The incidence of hypertension was higher in subjects with the highest FLI than in those with the lowest FLI (Q4, 9,968 [11.9%] vs. Q1, 2,277 [2.7%]; p<0.001). There was a significant correlation between the highest FLI and an increased risk of new-onset hypertension (adjusted hazard ratio between Q4 and Q1, 2.330; 95% confidence interval, 2.218-2.448; p<0.001). FLI was significantly associated with an increased risk of new-onset hypertension regardless of baseline characteristics.
CONCLUSIONS: Higher FLI was independently associated with increased risk of hypertension in a healthy Korean population.
Copyright © 2020. The Korean Society of Cardiology.

Entities:  

Keywords:  Fatty liver, nonalcoholic; Healthy people programs; Hypertension

Year:  2020        PMID: 32281324     DOI: 10.4070/kcj.2019.0379

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  6 in total

1.  Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.

Authors:  Gai Gao; Zhishen Xie; Er-Wen Li; Yong Yuan; Yu Fu; Pan Wang; Xiaowei Zhang; Yonghui Qiao; Jiangyan Xu; Christian Hölscher; Hui Wang; Zhenqiang Zhang
Journal:  J Nat Med       Date:  2021-02-15       Impact factor: 2.343

2.  Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and Hypertension: One Concept Fits Multi-systemic Presentations.

Authors:  Mi Jeong Kim
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

3.  Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.

Authors:  Stefano Ciardullo; Guido Grassi; Giuseppe Mancia; Gianluca Perseghin
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-04-01       Impact factor: 2.566

4.  Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.

Authors:  Masato Furuhashi; Yu Kataoka; Ryo Nishikawa; Masayuki Koyama; Akiko Sakai; Yukimura Higashiura; Marenao Tanaka; Shigeyuki Saitoh; Kazuaki Shimamoto; Hirofumi Ohnishi
Journal:  J Atheroscler Thromb       Date:  2021-09-25       Impact factor: 4.394

5.  Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.

Authors:  Masato Furuhashi; Yukimura Higashiura; Masayuki Koyama; Marenao Tanaka; Takayo Murase; Takashi Nakamura; Seigo Akari; Akiko Sakai; Kazuma Mori; Hirofumi Ohnishi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Hypertens Res       Date:  2021-06-11       Impact factor: 3.872

6.  The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis.

Authors:  Chongyang Ma; Kai Yan; Zisong Wang; Qiuyun Zhang; Lianyin Gao; Tian Xu; Jiayang Sai; Fafeng Cheng; Yuqiong Du
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.